Adenocarcinoma, Papillary - 3 Studies Found

Not yet recruiting : Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
:
  • Adenoid Cystic Carcinoma
  • Adnexal Carcinoma
  • Apocrine Carcin
    : 2016-11-30
    :
    • Other: Laboratory Biomarker Analysis

Active, not recruiting : Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
:
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Seromucinous Carcinoma
  • Drug: Everolimus Given PO
Active, not recruiting : Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
:
  • Deleterious BRCA1 Gene Mutation
  • Deleterious BRCA2 Gene Mutation
  • Drug: Cediranib Maleate Given